Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Caribou Biosciences (CRBU)

Caribou Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CRBU
DateTimeSourceHeadlineSymbolCompany
16/01/202510:45PR Newswire (US)CRBU LAWSUIT ALERT: The Gross Law Firm Notifies Caribou Biosciences, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineNASDAQ:CRBUCaribou Biosciences Inc
13/01/202513:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBUCaribou Biosciences Inc
13/01/202510:45PR Newswire (US)Shareholders of Caribou Biosciences, Inc. Should Contact The Gross Law Firm Before February 24, 2025 to Discuss Your Rights - CRBUNASDAQ:CRBUCaribou Biosciences Inc
13/01/202500:05GlobeNewswire Inc.Caribou Biosciences Initiates the CB-010 GALLOP Phase 1 Trial in Lupus and Provides Outlook for Multiple Clinical Datasets in 2025NASDAQ:CRBUCaribou Biosciences Inc
10/01/202522:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
10/01/202521:55Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
09/01/202510:45PR Newswire (US)Class Action Filed Against Caribou Biosciences, Inc. (CRBU) Seeking Recovery for Investors - Contact The Gross Law FirmNASDAQ:CRBUCaribou Biosciences Inc
07/01/202521:00GlobeNewswire Inc.Caribou Biosciences to Present at 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:CRBUCaribou Biosciences Inc
06/01/202510:45PR Newswire (US)The Gross Law Firm Reminds Caribou Biosciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 24, 2025 - CRBUNASDAQ:CRBUCaribou Biosciences Inc
02/01/202517:50PR Newswire (US)Class Action Filed Against Caribou Biosciences, Inc. (CRBU) Seeking Recovery for Investors - Contact The Gross Law FirmNASDAQ:CRBUCaribou Biosciences Inc
02/01/202513:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBUCaribou Biosciences Inc
02/01/202513:00GlobeNewswire Inc.Caribou Biosciences Appoints Sri Ryali as Chief Financial OfficerNASDAQ:CRBUCaribou Biosciences Inc
06/12/202421:06Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:CRBUCaribou Biosciences Inc
22/11/202421:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
20/11/202421:00GlobeNewswire Inc.Caribou Biosciences to Participate in Upcoming Investor ConferencesNASDAQ:CRBUCaribou Biosciences Inc
14/11/202423:08Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CRBUCaribou Biosciences Inc
06/11/202421:08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRBUCaribou Biosciences Inc
06/11/202421:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBUCaribou Biosciences Inc
06/11/202421:05GlobeNewswire Inc.Caribou Biosciences Reports Third Quarter 2024 Financial Results and  Provides Business UpdateNASDAQ:CRBUCaribou Biosciences Inc
04/10/202420:02Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
27/09/202420:02Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:CRBUCaribou Biosciences Inc
25/09/202413:00GlobeNewswire Inc.Caribou Biosciences to Present Preclinical Data Supporting Development of CB-010 for Lupus at the American College of Rheumatology Convergence 2024NASDAQ:CRBUCaribou Biosciences Inc
03/09/202420:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBUCaribou Biosciences Inc
03/09/202412:00GlobeNewswire Inc.Caribou Biosciences Announces the FDA has Granted Fast Track Designations to CB-010 in Refractory SLE and to CB-012 in Relapsed or Refractory AMLNASDAQ:CRBUCaribou Biosciences Inc
26/08/202420:00GlobeNewswire Inc.Caribou Biosciences to Participate in Upcoming Investor ConferencesNASDAQ:CRBUCaribou Biosciences Inc
20/08/202420:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
20/08/202420:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
12/08/202412:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBUCaribou Biosciences Inc
12/08/202412:00GlobeNewswire Inc.Caribou Biosciences Appoints Tina Albertson, MD, PhD, as Chief Medical OfficerNASDAQ:CRBUCaribou Biosciences Inc
06/08/202420:08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRBUCaribou Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:CRBU